Golden House Ltd (TLV:GOHO)
Israel · Delayed Price · Currency is ILS · Price in ILA 1,098.00
-2.00 (-0.18%)
Aug 24, 2026, 11:02 AM IDT
Golden House Market Cap
Golden House has a market cap or net worth of 170.68 million as of August 21, 2026. Its market cap has decreased by -14.40% in one year.
Market Cap
170.68M
Enterprise Value
129.71M
Revenue
46.05M
Ranking
n/a
PE Ratio
n/a
Stock Price
1,098.00
ChartMarket Cap Chart
Since March 30, 2006, Golden House's market cap has increased from 74.77M to 170.68M, an increase of 128.27%. That is a compound annual growth rate of 4.13%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 24, 2026 | 170.68M | 7.63% |
| Dec 31, 2025 | 158.58M | -55.97% |
| Dec 31, 2024 | 360.14M | 47.35% |
| Dec 31, 2023 | 244.41M | 50.96% |
| Dec 29, 2022 | 161.90M | -36.51% |
| Dec 30, 2021 | 255.00M | 16.75% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 130.06B |
| Danel (Adir Yeoshua) | 2.53B |
| Amal Holdings A.D. | 2.32B |
| BrainsWay | 1.81B |
| Novolog (Pharm-Up 1966) | 378.05M |
| Geffen Residence & Renewal | 334.04M |
| Bonus BioGroup | 212.60M |
| InterCure | 143.37M |